← FDA Warning Letters
Aurobindo Pharmaceutical Limited
FDA Warning Letter · 2022-01-25 · Center for Drug Evaluation and Research | CDER
Letter
- Company
- Aurobindo Pharmaceutical Limited
- Posted Date
- 2022-01-25
- Letter Issue Date
- 2022-01-12
- Issuing Office
- Center for Drug Evaluation and Research | CDER
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown